Skip to content

Brought to you by

Dentons logo

Canada Regulatory Review

The latest information and developments on regulatory law across Canada.

open menu close menu

Canada Regulatory Review

  • Home
  • About Us
  • Dentons COVID-19 hub

Health Canada is watching! Businesses marketing products with anti-microbial claims should proceed with care

By Monica Song and Yulia Konarski
July 12, 2021
  • Health
  • Product regulation
  • Public Policy and Regulation
  • Regulatory
Share on Facebook Share on Twitter Share via email Share on LinkedIn

For many businesses, the COVID-19 pandemic saw the advent of new sources of demand for sanitizing products for personal use or in public environments, stimulating the growth of anti-microbial claims being made in relation to existing products or the development of new products making such claims. From UV disinfecting wands and air filters for the home to disinfecting sprays for high-touch surfaces in public spaces, the demand is there and the market looks to be here to stay.

From a business perspective, widely advertising any and all anti-microbial properties a product may have to capitalize on the market potential of these types of products makes perfect sense.   However, improper anti-microbial claims may trigger compliance issues for your business.   Among other issues, consumer products generally and health products in particular are classified based upon how the product is “manufactured, sold or represented for use.” An anti-microbial claim, e.g., “useful against COVID-19” or “kills 99% of bacteria” may affect the regulatory classification of a product.  In turn, the re-classification of a product may trigger a host of regulatory requirements, such as product approval, registration, labelling, site licencing etc.  Where non-compliance is found, enforcement can include stop-sale or recall requirements until the claim is removed from the marketplace or the product is otherwise brought into compliance.

Health Canada is on high alert for products claiming to be effective against COVID-19 or more generally against any virus, bacteria, irritants, disease and the like and the regulatory landscape for these products is in rapid flux. The lines between different regulatory regimes have blurred, bringing to the fore novel questions of interpretation and application. Some examples of recent developments include:

  • At the start of the pandemic, Health Canada issued an advisory regarding false or misleading claims to prevent, treat or cure COVID-19. Health Canada clearly signalled its intent to monitor all such claims, stating, “selling or advertising health products that make false or misleading claims is illegal. The Department takes this issue seriously and will not hesitate to use all mechanisms and tools at its disposal to stop these activities.” This increased monitoring of products making inappropriate anti-microbial claims is expected to extend to general anti-microbial claims.
  • In March of this year, the Pest Management Regulatory Agency (PMRA) of Health Canada issued an information note that “treated articles”, i.e. consumer goods or goods sold business to business that claim to have anti-microbial properties based on the incorporation of a pest control agent in the good, may be themselves considered pest control products requiring registration under the Pest Control Products Act (PCPA).
  • In June, the Interim order regulating certain UV radiation-emitting and ozone-generating devices under the Pest Control Products Act (June IO) came into effect. The June IO clarifies that certain ultraviolet radiation-emitting devices and ozone-generating devices claiming to kill bacteria and viruses are pest control products subject to the regulatory requirements of the PCPA, including the requirement to register and additional labelling requirements.
  • By contrast, devices including UV wands and air filters, which make claims beyond simply killing microbes but also claim to prevent infection with COVID-19 or other illnesses are exempt from application of the June IO, but may be regulated as a medical device.

Judging from the rapid pace at which Health Canada is issuing iterative guidance and passing new legislation that introduces new regulatory requirements for products making these claims, Health Canada is clearly on the alert for products making anti-microbial claims. 

One thing is certain in this evolving regulatory landscape: there is a high risk Health Canada will detect products making anti-microbial claims that may be non-compliant with one or more regulatory regimes triggered by the anti-microbial claim – be it for pest control products, medical devices, drugs or natural health products.

Please contact Monica Song or Yulia Konarski if you have any questions about how your product may be regulated in Canada.

Share on Facebook Share on Twitter Share via email Share on LinkedIn
Subscribe and stay updated
Receive our latest blog posts by email.
Stay in Touch
Monica Song

About Monica Song

Monica Song leads the Communications Law group of Dentons Canada LLP. A skilled administrative lawyer with in-depth knowledge of the business, legal, regulatory, licensing, and public policy issues affecting the communications industry, she has over 20 years’ experience advising clients in the sector, including wireline and wireless carriers, resellers, satellite operators, cable companies, Internet service providers, cloud-based application service providers, digital media undertakings, content providers, and equipment manufacturers and distributors. She also oversees the provision of tailored commercial, access to information, lawful access, lobbying, privacy, marketing and advertising, copyright and transactional advisory services to clients in the sector.

All posts Full bio

Yulia Konarski

About Yulia Konarski

Yulia Konarski is an associate in our Regulatory group with a practice that focuses on regulated products under the Food and Drugs Act, including food, drugs, natural health products, cosmetics and medical devices. Yulia regularly advises clients about their obligations in relation to importing and selling these products into Canada.

All posts Full bio

RELATED POSTS

  • COVID-19
  • Health
  • Litigation and Dispute Resolution
  • Privacy
  • Public Policy and Regulation
  • Regulatory

Dentons HealthTech in Canada podcast

By Dina Awad, Rose Carter, Dan Collins, and Tom Sides | May 11, 2020
  • Energy
  • Public Policy and Regulation
  • Regulatory

Energy Regulation in the New Dynamic: Dentons Revisits its Pick of Canadian Regulatory Trends to Watch in 2020

By Simon Kupi | September 18, 2020
  • International Trade
  • Public Policy and Regulation
  • Regulatory
  • Trade, WTO and Customs

United States re-imposes aluminum tariffs on certain Canadian aluminum products

By Paul Lalonde and Sean Stephenson | August 14, 2020

About Dentons

Dentons is designed to be different. As the world’s largest law firm with 20,000 professionals in over 200 locations in more than 80 countries, we can help you grow, protect, operate and finance your business. Our polycentric and purpose-driven approach, together with our commitment to inclusion, diversity, equity and ESG, ensures we challenge the status quo to stay focused on what matters most to you. www.dentons.com

Dentons boilerplate image

Twitter

Categories

  • Aboriginal
  • Administrative Law
  • Anti-Corruption
  • Anti-Money Laundering
  • Aviation
  • Broadcasting
  • Cannabis
  • Class Action Defense
  • Climate Change
  • Climate Change
  • Commercial Litigation
  • Communications
  • Competition
  • Consumer Products
  • COVID-19
  • Data
  • Drones
  • Energy
  • Environmental
  • ESG
  • Event
  • Expropriation
  • Financial
  • FinTech
  • Foreign Investment Review
  • Franchising and Distribution
  • Global Mobility
  • Government Affairs
  • Government Investigations
  • Health
  • Immigration
  • International Trade
  • Judicial Review
  • Litigation and Dispute Resolution
  • Marketing/Advertising
  • Mergers & Acquisitions
  • Mining
  • Modern Slavery
  • Municipal
  • National Security
  • Privacy
  • Privacy and Cybersecurity
  • Product regulation
  • Professional Liability
  • Public Policy and Regulation
  • Public Procurement
  • Real Estate
  • Regulatory
  • Russia
  • Sanctions
  • Securities
  • Smart Cities
  • Supply chain
  • Tax
  • Technology
  • Technology, Media and Communications
  • Trade and Economic Sanctions
  • Trade, WTO and Customs
  • Transportation
  • Ukraine/Russia
  • White Collar Crime
Dentons logo

© 2023 Dentons

  • Legal notices
  • Privacy policy
  • Terms of use
  • Cookies on this site